InvestorsHub Logo
icon url

jta1980

10/13/22 2:57 PM

#377524 RE: JKS3 #377521

Exactly, WTF?
Our study must be much more comprehensive, right?!
icon url

tredenwater2

10/13/22 7:57 PM

#377557 RE: JKS3 #377521

BIIB and Eisai have 1800 patients. It took 3 weeks.



Rushing around throwing out big numbers and reduction in decline numbers works for some but does it work for the patient? Judging by their last attempt to with their last drug , whether its 1800 or 18,000 patients, their trial model is not one to use as an example for anything imo.

Rush rush rush and nobody wants it so you pull it, yeah…..thats the ticket!